Vanderbilt University
Vanderbilt is a leading private research university with strong commercialization in biomedical sciences, neuroscience, and data science.
Research and Commercialization Data
Total R&D Expenditures
- Research spending (FY2024): $1.3B total, of which $86.1M was funded by business. NSF National Center for Science and Engineering Statistics NSF reporting unit: Vanderbilt U. and Vanderbilt U. Medical Center.
- US patents granted (2025): 52 (rank #44). National Academy of Inventors
- Tech transfer (FY2025): 231 invention disclosures, 284 patent applications, 104 licenses and options, 16 startups, $13.6M licensing revenue. Vanderbilt Center for Technology Transfer and Commercialization
Research Focus Areas
Biomedical Sciences
Cancer, cardiovascular, and infectious disease
Neuroscience
Brain disorders and neural circuits
Data Science & AI
Machine learning and health informatics
Related Market Maps
Explore market opportunities in deep tech categories relevant to Vanderbilt's research focus.
Biotechnology
13.96% CAGRApplication of biological systems and organisms to develop products and technologies
Neurotechnology
13% CAGRTechnologies interfacing with the nervous system for medical and research applications
Quantum Computing
34.6% CAGRRevolutionary computing technology leveraging quantum mechanics for exponential speedups in specific problem domains
Notable Spinouts
Programs & Resources
Tech Transfer Office
Vanderbilt Center for Technology Transfer and Commercialization (CTTC)
IP Portfolio Available
~181 technologies available for licensing
Platform: Custom
Browse IP PortfolioServices Offered
- •IP management
- •Licensing
- •Startup support
- •Industry partnerships
Interested in Tech Transfer?
Learn how to navigate university licensing and commercialization